Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient populationCharles E. Mahan, Alex C. Spyropoulos, Judith J. Stephenson et al.|Thrombosis Research|2013Cited by 55
Antithrombotic Medication Use and Bleeding Risk in Medically Ill Patients After HospitalizationCharles E. Mahan, Winslow Klaskala, Larry E. Fields et al.|Clinical and Applied Thrombosis/Hemostasis|2013Cited by 15
IMPACT OF COMORBIDITIES ON TIME IN THERAPEUTIC RANGE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATIONJiyoon Choi, Winnie W. Nelson, C.V. Damaraju et al.|Journal of the American College of Cardiology|2012Cited by 4
All-cause mortality and use of antithrombotics within 90 days of discharge in acutely ill medical patientsCharles E. Mahan, Alex C. Spyropoulos, Larry E. Fields et al.|Thrombosis and Haemostasis|2015Cited by 2
PCV3 Evaluation of VTE Prophylaxis, Surgical Site Bleeding, and Surgical-Site Infections Following Orthopaedic Arthroplasty: A Nested Case–Control Medical Chart Review StudyMary L. Fisher, M. H. Huo, Judith J. Stephenson et al.|Value in Health|2012Cited by 0